Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike

September 4, 2016

Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.

epipen alternative
Mark Baum / Imprimis Pharmceuticals

Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.

"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.

"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."


feel good videoDogs Are Forced To Wear The Things They Steal — And It’s Hilarious

feel good storiesMeet Chonkers - The 2,000-Pound Sea Lion Taking Over San Francisco’s Pier 39

feel good storiesMom Left Speechless After Reading Son’s Mother’s Day School Assignment

feel good storiesThis Groundhog’s Dig Revealed a 19,000-Year-Old Secret

feel good storiesMeet Casper, the Single Owl Mom Who Has Raised More Than 500 Orphaned Babies

feel good videoThey Put a German Shepherd in Charge of Babysitting a Group of Doberman Puppies

feel good videoDog Watches Man Throw Football on TV and Has the Most Hilarious Reaction

feel good videoUPS Driver Hailed a Hero After Saving Little Calf

feel good videoRetired Dad Finds His True Calling Cuddling Babies in the NICU

feel good videoStudent Gets Teacher’s Handwritten Words Tattooed on Her and His Reaction Says Everything